Strados Labs developed the first-of-its-kind, FDA approved Respiratory Management Solution, RESP™. This wearable monitor listens and captures breathing patterns and lung acoustics for clinicians in a non-invasive, non-intrusive, and wireless way that ensures patient compliance. At the end of 2020, Strados received 510K clearance from the Food and Drug Administration for RESP™ and was in search of an agency to help propel their messaging and brand forward, while creating thought leadership with its CEO, Nick Delmonico. The company engaged Inspire to create a strategic communications and marketing plan and execute on it to help attract investors, create brand awareness and drive leads.
Inspire gave Strados a distinct brand voice and messaging to effectively tell the company’s story. We redesigned the company website and investor deck, while undertaking public relations outreach and pitching media on the FDA clearance, CE Mark, RESP advancements, new partnerships, new board members and more. Inspire develops social media content, thought leadership pieces and videos, as well as email templates for HubSpot deployment.
The new attractive and interactive investor deck is receiving positive comments from investors, and the company’s message and ask is now clear and concise. The company has also established a social footprint with an audience of >1,600 community members. Engagement has increased steadily, more than tripling over the past six months. We expect to have more results to report as soon as metrics come in for the new website, as well as the new thought leader videos and testimonials.
HubSpot integrated email
social media compaign